Market Pulse Archives

Oct. 11, 2021, 6:30 a.m. EDT

Coronavirus tally: Global cases of COVID-19 near 238 million as Merck sees FDA approval for antiviral

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Merck & Co. Inc. (MRK)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to data aggregated by Johns Hopkins University . The U.S. continues to lead the world with a total of 44.3 million cases and 713,350 deaths. The U.S. is again averaging 2,000 deaths a day, according to a New York Times tracker, , although new cases and hospitalizations are declining. Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +2.03% submitted an application for Emergency Use Authorization (EUA) with the Food and Drug Administration for molnupiravir, their oral antiviral medicine for the treatment of mild-to-moderate COVID-19 in adults. The company had disclosed that data from a Phase 3 trial found the treatment reduced the risk of of hospitalization or death in adults at risk for progressing to severe COVID-19 by 50%. India is second by cases after the U.S. at 33.9 million and has suffered 450,782 deaths. Brazil has second highest death toll at 601,011 and 21.6 million cases. In Europe, Russia has most fatalities at 213,522, followed by the U.K. at 138,139.

$ 106.93
+2.13 +2.03%
Volume: 7.56M
March 27, 2023 4:03p
P/E Ratio
Dividend Yield
Market Cap
$266.04 billion
Rev. per Employee

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.